Press releases
Omega Pharma attaches great importance to regular and transparent communication with its stakeholders. The publication of press releases plays an important role in this communication flow. All press releases of the past five years are available on this web site. Do you wish to receive our press releases henceforward free of charge via e-mail? Please subscribe by using the button on the home page.
2010
10/03/2010: Annual Results 2009
21/01/2010: Trading Update 4th quarter and full-year 2009
2009
09/11/2009: Omega Pharma sells 24.04% interest in Arseus
15/10/2009: Trading Update 3rd quarter 2009
09/10/2009: Omega Pharma sells French production unit
25/09/2009: Disclosure in accordance with the Law of May 2, 2007
25/09/2009: Notification form Capital Group Intl 24 Sept 09
31/08/2009: Georges De Vos named COO of Omega Pharma
27/08/2009: Interim Financial Report 1st half year 2009
27/08/2009: Press release results 1st half 2009
16/07/2009: Trading Update 2nd quarter and 1st half 2009
09/06/2009: New statutory notification thresholds for participations
15/05/2009: Convocation to the Extraordinary General Meeting of 9 June 2009
15/05/2009: Proxy Extraordinary Shareholder Meeting 9 June 2009
28/04/2009: Press conference 28 April 2009
16/04/2009: Trading Update 1st quarter 2009
30/03/2009: Convocation to the Extraordinary and Annual General Meeting of 4 May 2009
30/03/2009: Proxy form for the Annual Meeting of 4 May 2009
30/03/2009: Proxy form for the Extraordinary General Meeting of 4 May 2009
12/03/2009: Annual Results 2008
22/01/2009: Trading Update 4th quarter and full-year 2008
2008
04/11/2008: Notification of participation by Capital Group International
04/11/2008: Notification of 4.90% participation by Capital Group International
04/11/2008: Notification of 5.86% participation by Capital Group International
16/10/2008: Trading Update 3rd quarter 2008
26/09/2008: Disclosure of shareholdings in accordance with the law of May 2, 2007
26/09/2008: Base declaration of Couckinvest and M.Coucke in accordance with the law of May 2, 2007
26/09/2008: Base declaration of Omega Pharma in accordance with the law of May 2, 2007
12/09/2008: New strategy announced at the occasion of the Investors Day
12/09/2008: Disclosure in accordance with the Law of May 2, 2007
28/08/2008: Press release 1st half year 2008 results
28/08/2008: Interim Financial Report 1st half year 2008
17/07/2008: Trading update second quarter 2008
02/07/2008: Notification of participation by Omega Pharma (treasury shares)
10/06/2008: Notification of participation by Marc Coucke/Couckinvest NV
10/06/2008: Notification of participation by Omega Pharma (treasury shares)
16/05/2008: Convocation to the Extraordinary Shareholder Meeting of 9 June 2008
16/05/2008: Proxy Extraordinary Shareholder Meeting 9 June 2008
05/05/2008: Presentation ASM 5 May 2008
05/05/2008: Brief overview of voting results ASM 5 May 2008
05/05/2008: Minutes ASM 5 May 2008 (selected translations)
17/04/2008: Omega Pharma Trading Update 1st Quarter 2008
31/03/2008: Proxy form for Annual Meeting 5 May 2008
31/03/2008: Proxy form for Extraordinary Shareholders Meeting 5 May 2008
31/03/2008: Convocation General Shareholders Meeting 5 May 2008
13/03/2008: Omega Pharma 2007 Results
13/03/2008: Condensed consolidated financial statement 2007
13/03/2008: Profile Lucas Laureys
12/02/2008: Official notification
17/01/2008: Trading Update 4th quarter and full-year 2007
2007
31/12/2007: Complementary annual information 2007
28/12/2007: Notification of participation by Omega Pharma (treasury shares)
14/12/2007: Omega Pharma remains cycling sponsor with Silence until 2011
04/12/2007: Notification of participation by Omega Pharma (treasury shares)
21/11/2007: Omega Pharma intends to buy back 2 million shares
08/11/2007: Result of the stabilisation program of the Arseus IPO
18/10/2007: Omega Pharma trading update 3rd quarter 2007
18/10/2007: Arseus trading update 3rd quarter 2007
04/10/2007: Arseus realises successful IPO at EUR 10.25 per share
04/10/2007: Arseus IPO - result of the offering
04/10/2007: Placard - official insertion (Dutch language only) on result of the offering re Arseus IPO
02/10/2007: Summary declaration of interest Couckinvest NV, Marc Coucked (2 Oct. 2007)
02/10/2007: Arseus IPO - earling closing of the Offering
21/09/2007: Press release announcement price range IPO Arseus
06/09/2007: Arseus has assured credit facilities after IPO
29/08/2007: Financial statement first half-year 2007
29/08/2007: Results first half year 2007
08/08/2007: Declaration of interest by Goldman Sachs Group, Inc
19/07/2007: Trading Update Second Quarter 2007
04/07/2007: Arseus is accelerating its IPO plan
18/06/2007: Convocation to the Extraordinary Shareholder Meeting of 6 July 2007
18/06/2007: Proxy Extraordinary Shareholder Meeting 6 July 2007
04/06/2007: Arseus acquires activities of Polichimica (Italy)
11/05/2007: Convocation to Annual & Extraordinary Shareholders Meeting of 4 June 2007
11/05/2007: Proxy Extraordinary Shareholder Meeting 4 June 2007
11/05/2007: Proxy ordinary general meeting 4 June 2007
19/04/2007: Omega Pharma Trading Update First Quarter of 2007
19/04/2007: Declaration of interest by Goldman Sachs Group, Inc
16/04/2007: Omega Pharma strengthens Executive Committee
05/04/2007: Omega Pharma acquires Persee Médica
05/04/2007: Presentation acquisition Persee Medica
21/03/2007: Corilus is the new name for OmegaSoft
15/03/2007: Omega Pharma 2006 Results
15/03/2007: Condensed consolidated financial statement 2006
01/03/2007: Presentation Analyst Meeting 1 March 2007
28/02/2007: New home diagnostic products launched under Predictor brand in Belgium
08/02/2007: Omega Pharma is in track for an IPO of Arseus in 2008
19/01/2007: Sales Flash 4th quarter and full year 2006
18/01/2007: Convocation to the Extraordinary Shareholder Meeting of 12 February 2007
18/01/2007: Proxy Extraordinary Shareholder Meeting 12 February 2007
12/01/2007: Omega Pharma strengthens management
2006
22/12/2006: Convocation to the Extraordinary Shareholder Meeting of 12 January 2007
22/12/2006: Proxy Extraordinary Shareholder Meeting 12 January 2007
23/11/2006: Press release 3rd quarter 2006 results
17/11/2006: Convocation to the Extraordinary Shareholder Meeting of 14 December 2006
17/11/2006: Proxy Extraordinary Shareholder Meeting 14 December 2006
07/11/2006: Omega Pharma to repeat Davitamon sponsoring success with Predictor
24/10/2006: Omega Pharma acquires Bittner Pharma Group
16/10/2006: Sales flash 3rd quarter 2006
14/09/2006: New Omega Pharma CEO
14/09/2006: Profile Jan Cassiman
07/09/2006: Results first half 2006
07/09/2006: Financial statement first half-year 2006
18/07/2006: Sales flash 2nd quarter and 1st half 2006
06/07/2006: ESM approves cancellation of 5% of shares
16/06/2006: Convocation to the Extraordinary Shareholders Meeting of 6 July 2006
12/06/2006: Professional Health division renamed Arseus
24/05/2006: Results 1st quarter 2006
12/05/2006: Omega Pharma plans acquisition of Bional group
11/05/2006: Convocation to Annual & Extraordinary Shareholders Meeting of 6 June 06
24/04/2006: Omega Pharma joints European OTC Alliance
13/04/2006: Sales Flash 1st quarter 2006
16/03/2006: Consolidated Results 2005
12/01/2006: Sales flash 2005
2005
07/01/2005: Change in Executive Committee 
15/01/2005: Sales Flash 4th quarter 2004
22/03/2005: Consolidated results for the financial year 2004
14/04/2005: Sales Flash Q1/2005
26/05/2005: Consolidated results for the first quarter 2005
07/06/2005: Announcement: 2004 dividend becomes payable
15/07/2005: Sales Flash first semester 2005
08/09/2005: Consolidated results for the first semester of 2005
13/10/2005: Sales Flash Q3/2005
24/11/2005: Consolidated results for the 3rd quarter 2005
25/11/2005: Omega Pharma prepares IPO for its B2B activities (“professional health”)
2004
08/01/2004: Financial calendar 2004
15/01/2004: Sales Flash
25/03/2004: Consolidated Results 2003
06/04/2004: Omega Pharma acquires Wartner Europe
15/04/2004: Sales Flash 1st quarter 2004
26/05/2004: Omega Pharma acquires a portfolio of OTC and personal care brands from Pfizer
26/05/2004: Results 1st quarter 2004
02/07/2004: Meda acquires Cyklokapron and Cyklo-F
04/07/2004: Sales Flash 2nd quarter 2004
03/09/2004: Omega Pharma fully operational in 17 European countries following two important acquisitions
09/09/2004: Results 1st half year 2004
14/10/2004: Sales Flash 3rd quarter 2004
18/10/2004: “Farma 2004” trade fair: report
19/11/2004: Accounting effects of 2004 acquisitions
24/11/2004: Results 3rd quarter 2004
09/12/2004: Annual prognosis 2004
2003
20/01/2003: Omega Pharma acquires strong OTC organizations in Greece, Portugal and France
29/01/2003: Omega Pharma achieves European structure for B2B activities towards pharmacists
31/01/2003: Sales Flash 2002
06/02/2003: Letter to the shareholders
19/03/2003: Consolidated results 2002
15/05/2003: Results 1st quarter 2003
30/05/2003: Pharmacia has decided to terminate the collaboration with Omega Pharma
03/06/2003: Notice of dividend payment
17/07/2003: Omega Pharma becomes main sponsor of new cycling team Bodysol-Brustor
07/08/2003: Sales Flash 2nd quarter 2003
02/09/2003: Omega Pharma becomes exclusive distributor of Medicinal Cannabis in the Netherlands
15/09/2003: Consolidated Results for the first semester of 2003
05/11/2003: Bodysol and Poudres T. LeClerc expanding strongly in Belgium
05/11/2003: Omega Dental expands to Germany
17/11/2003: Results 3rd quarter 2003
2002
19/03/2002: Consolidated results 2001
15/05/2002: Results 1st quarter 2002
03/06/2002: Omega Pharma presents strategy at ASM
04/06/2002: Bericht van betaalbaarstelling van het dividend/Dividende – mise en paiement
02/07/2002: Omega Pharma acquires OTC company in France
05/07/2002: Omega Pharma acquires Oudheusden Dental BV
22/07/2002: Omega Pharma sponsors the new cycling team Quick-Step/Davitamon
16/12/2002: Revision of 2002 perspectives
